New Leaf Venture Partners as of June 30, 2016
Portfolio Holdings for New Leaf Venture Partners
New Leaf Venture Partners holds 14 positions in its portfolio as reported in the June 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Edge Therapeutics | 20.4 | $24M | 2.3M | 10.11 | |
Versartis | 19.4 | $23M | 2.0M | 11.06 | |
Wave Life Sciences (WVE) | 14.0 | $16M | 784k | 20.69 | |
Oxford Immunotec Global | 10.7 | $12M | 1.4M | 9.00 | |
Dimension Therapeutics | 10.6 | $12M | 2.1M | 6.00 | |
Dynavax Technologies (DVAX) | 5.7 | $6.6M | 455k | 14.58 | |
Dermira | 5.0 | $5.7M | 197k | 29.25 | |
Alder Biopharmaceuticals | 4.1 | $4.8M | 191k | 24.97 | |
Sage Therapeutics (SAGE) | 4.1 | $4.7M | 157k | 30.13 | |
AVEO Pharmaceuticals | 2.1 | $2.5M | 2.6M | 0.96 | |
Karyopharm Therapeutics (KPTI) | 1.3 | $1.5M | 223k | 6.71 | |
Vistagen Therapeutics | 1.2 | $1.4M | 353k | 3.90 | |
Adaptimmune Therapeutics (ADAP) | 0.9 | $1.0M | 127k | 8.15 | |
Trillium Therapeutics, Inc. Cmn | 0.6 | $725k | 81k | 8.98 |